Press Releases
Keyword Search
| Date | Title | ||
|---|---|---|---|
|
02/19/20
|
Summary ToggleT2 Biosystems to Participate in the SVB Leerink Global Healthcare Conference |
|
LEXINGTON, Mass. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming SVB Leerink Global Healthcare Conference in New York, New York . |
|
02/12/20
|
Summary ToggleT2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 |
|
LEXINGTON, Mass. , Feb. 12, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020. |
|
02/04/20
|
Summary ToggleT2 Biosystems Announces Participation at Clinical Conferences in February |
|
Company will highlight need for rapid detection of sepsis-causing pathogens LEXINGTON, Mass. , Feb. 04, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the Company’s participation in two conferences in |
|
01/17/20
|
Summary ToggleT2 Biosystems Reports Granting of Inducement Award |
|
LEXINGTON, Mass. , Jan. 17, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sperzel , |
|
01/13/20
|
Summary ToggleT2 Biosystems Promotes Tony Pare to Chief Commercial Officer |
|
LEXINGTON, Mass. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Chief Executive Officer (CEO), John Sperzel , has promoted Tony Pare to the newly |
|
01/09/20
|
Summary ToggleT2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results |
|
Enters Exclusive Distribution Agreement to Expand Sales in Israel LEXINGTON, Mass. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced preliminary revenue and |
|
01/09/20
|
Summary ToggleT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer |
|
LEXINGTON, Mass. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Board of Directors has appointed diagnostics industry veteran John Sperzel as |